Genomic Medicine Program Advisory Committee; Notice of Meeting, 15207 [2014-05901]
Download as PDF
Federal Register / Vol. 79, No. 52 / Tuesday, March 18, 2014 / Notices
emcdonald on DSK67QTVN1PROD with NOTICES
copies of the information collection
package should be directed to Yvonne
Pollard; Compliance Branch; United
States Mint; 801 9th Street, NW., 5th
Floor; Washington, DC 20220; (202)
354–6784 (this is not a toll-free
number); YPollard@usmint.treas.gov.
SUPPLEMENTARY INFORMATION:
Title: Application for Intellectual
Property Use Form.
OMB Number: 1525–0013
Abstract: The application form allows
individuals and entities to apply for
permissions and licenses to use United
States Mint owned or controlled
intellectual property.
Current Actions: The United States
Mint reviews and assesses permission
requests and applications for United
States Mint intellectual property
licenses.
Type of Review: Renewal of a
currently approved information
collection.
Affected Public: Businesses or otherfor-profit; not-for-profit institutions;
State, Local, or Tribal Government; and
individuals or households.
Estimated Number of Respondents:
The estimated number of annual
respondents is 113.
Estimated Total Annual Burden
Hours: The estimated number of annual
burden hours is 84.
Requests For Comments: Comments
submitted in response to this notice will
be summarized and/or included in the
request for Office of Management and
Budget (OMB) approval. All comments
will become a matter of public record.
Comments are invited on: (a) Whether
the collection of information is
VerDate Mar<15>2010
18:34 Mar 17, 2014
Jkt 232001
necessary for the proper performance of
the functions of the agency, including
whether the information shall have
practical utility, (b) the accuracy of the
agency’s estimate of the burden of the
collection of information, (c) ways to
enhance the quality, utility, and clarity
of the information to be collected, (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology,
and (e) estimates of capital or start-up
costs and costs of operation,
maintenance, and purchase of services
to provide information.
Dated: March 12, 2014.
Richard A. Peterson,
Deputy Director, United States Mint.
[FR Doc. 2014–05977 Filed 3–17–14; 8:45 am]
BILLING CODE 4810–37–P
DEPARTMENT OF VETERANS
AFFAIRS
Genomic Medicine Program Advisory
Committee; Notice of Meeting
The Department of Veterans Affairs
(VA) gives notice under the Federal
Advisory Committee Act, 5 U.S.C. App.
2, that the Genomic Medicine Program
Advisory Committee will meet on April
18, 2014, at the American Association of
Airport Executives Conference Center,
at 601 Madison Street in Alexandria,
Virginia. The meeting will convene at
9:00 a.m. and adjourn at 5:00 p.m. The
meeting is open to the public.
PO 00000
Frm 00113
Fmt 4703
Sfmt 9990
15207
The purpose of the Committee is to
provide advice and make
recommendations to the Secretary of
Veterans Affairs on using genetic
information to optimize medical care for
Veterans and to enhance development
of tests and treatments for diseases
particularly relevant to Veterans.
The Committee will receive program
updates and continue to provide insight
into optimal ways for VA to incorporate
genomic information into its health care
program, while applying appropriate
ethical oversight and protecting the
privacy of Veterans. The meeting will
focus on developing infrastructure and
guidelines for genotyping and
phenotyping, and translation of
genomics into the clinic. The Committee
will also receive an update on the status
of the ongoing Million Veteran Program
and the Clinical Genomics Service. The
Committee will receive public
comments at 3:30 p.m. Public comments
will not exceed 5 minutes each.
Individuals who wish to speak may
submit a 1–2 page summary of their
comments for inclusion in the official
meeting record to Dr. Sumitra
Muralidhar, Designated Federal Officer,
810 Vermont Avenue NW., Washington,
DC 20420, or by email at
sumitra.muralidhar@va.gov. Any
member of the public seeking additional
information should contact Dr.
Muralidhar at (202) 443–5679.
Dated: March 13, 2014.
Rebecca Schiller,
Committee Management Officer.
[FR Doc. 2014–05901 Filed 3–17–14; 8:45 am]
BILLING CODE 8320–01–P
E:\FR\FM\18MRN1.SGM
18MRN1
Agencies
[Federal Register Volume 79, Number 52 (Tuesday, March 18, 2014)]
[Notices]
[Page 15207]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-05901]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF VETERANS AFFAIRS
Genomic Medicine Program Advisory Committee; Notice of Meeting
The Department of Veterans Affairs (VA) gives notice under the
Federal Advisory Committee Act, 5 U.S.C. App. 2, that the Genomic
Medicine Program Advisory Committee will meet on April 18, 2014, at the
American Association of Airport Executives Conference Center, at 601
Madison Street in Alexandria, Virginia. The meeting will convene at
9:00 a.m. and adjourn at 5:00 p.m. The meeting is open to the public.
The purpose of the Committee is to provide advice and make
recommendations to the Secretary of Veterans Affairs on using genetic
information to optimize medical care for Veterans and to enhance
development of tests and treatments for diseases particularly relevant
to Veterans.
The Committee will receive program updates and continue to provide
insight into optimal ways for VA to incorporate genomic information
into its health care program, while applying appropriate ethical
oversight and protecting the privacy of Veterans. The meeting will
focus on developing infrastructure and guidelines for genotyping and
phenotyping, and translation of genomics into the clinic. The Committee
will also receive an update on the status of the ongoing Million
Veteran Program and the Clinical Genomics Service. The Committee will
receive public comments at 3:30 p.m. Public comments will not exceed 5
minutes each. Individuals who wish to speak may submit a 1-2 page
summary of their comments for inclusion in the official meeting record
to Dr. Sumitra Muralidhar, Designated Federal Officer, 810 Vermont
Avenue NW., Washington, DC 20420, or by email at
sumitra.muralidhar@va.gov. Any member of the public seeking additional
information should contact Dr. Muralidhar at (202) 443-5679.
Dated: March 13, 2014.
Rebecca Schiller,
Committee Management Officer.
[FR Doc. 2014-05901 Filed 3-17-14; 8:45 am]
BILLING CODE 8320-01-P